Publications
The Open Archives of the University of Geneva constitute a dynamic digital platform which plays an essential role in the dissemination and preservation of the intellectual production of the institution. This initiative is part of the desire to promote free access to knowledge and promote the visibility of research work carried out within the university.
2024
Articles scientifiques
- YOUNESS, Rana A. et al. Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review. In: Non-coding RNA, 2024, vol. 10, n° 1, p. 7. doi: 10.3390/ncrna10010007
Thèses de doctorat
- DUPUYCHAFFRAY, Eloise. The impact of obesity on the response to immune checkpoint inhibitors. 2024. doi: 10.13097/archive-ouverte/unige:175564
2023
Articles scientifiques
- NAFEA, Heba et al. Dual targeting of H2S synthesizing enzymes; cystathionine β-synthase and cystathionine γ-lyase by miR-939-5p effectively curbs triple negative breast cancer. In: Heliyon, 2023, vol. 9, n° 10, p. e21063. doi: 10.1016/j.heliyon.2023.e21063
- SANTOS, Sidneia Sousa et al. Role of Cystathionine β-Synthase and 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation, Migration, and Bioenergetics of Murine Breast Cancer Cells. In: Antioxidants, 2023, vol. 12, n° 3, p. 647. doi: 10.3390/antiox12030647
2022
Articles scientifiques
- HOCEVAR, Sandra et al. PEGylated Gold Nanoparticles Target Age-Associated B Cells In Vivo. In: ACS nano, 2022. doi: 10.1021/acsnano.2c04871
- BOERSMA, Bart Nicolaas et al. Inhibition of IL-1β release from macrophages targeted with necrosulfonamide-loaded porous nanoparticles. In: Journal of controlled release, 2022, vol. 351, p. 989‑1002. doi: 10.1016/j.jconrel.2022.09.063
Thèses de doctorat
- TASKOPARAN YAGLIKCI, Betul. Role of Intratumoral HMGB1 in the Antitumor Immune Response. 2022. doi: 10.13097/archive-ouverte/unige:161873
2021
Articles scientifiques
- SPAGNUOLO, Lorenzo et al. HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer’s patches in homeostasis. In: European Journal of Immunology, 2021, vol. 51, n° 8, p. 1980‑1991. doi: 10.1002/eji.202049120
- BOERSMA, Bart Nicolaas et al. The interleukin-1 cytokine family members: role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy. In: Cytokine & growth factor reviews, 2021, vol. 62, p. 1‑14. doi: 10.1016/j.cytogfr.2021.09.004
- WAGNER, Julia et al. Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice. In: ACS Nano, 2021. doi: 10.1021/acsnano.0c08384
Thèses de doctorat
- WAGNER, Julia. Potential and Challenges in Improving Cancer Immunotherapy with Agonists for Nucleic Acid Sensors. 2021. doi: 10.13097/archive-ouverte/unige:154512
2020
Articles scientifiques
- HÉRAULT, Nelly et al. Silver-Containing Titanium Dioxide Nanocapsules for Combating Multidrug-Resistant Bacteria. In: International Journal of Nanomedicine, 2020, vol. 15, p. 1267‑1281. doi: 10.2147/IJN.S231949
Thèses de doctorat
- HOCEVAR, Sandra. Understanding the interactions of gold nanoparticles with B lymphocytes in vitro and in vivo. 2020. doi: 10.13097/archive-ouverte/unige:133930
2019
Articles scientifiques
- HOCEVAR, Sandra et al. Polymer-coated gold nanospheres do not impair the innate immune function of human B lymphocytes in vitro. In: ACS Nano, 2019. doi: 10.1021/acsnano.9b01492
- BOURQUIN, Carole, POMMIER, Aurélien, HOTZ, Christian. Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists. In: Pharmacological Research, 2019. doi: 10.1016/j.phrs.2019.03.001
- RAPP, Moritz et al. CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes. In: Journal of Experimental Medicine, 2019. doi: 10.1084/jem.20170277
- THAUVIN, Cédric et al. Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study. In: European Journal of Pharmaceutics and Biopharmaceutics, 2019. doi: 10.1016/j.ejpb.2019.04.007
- BOURQUIN, Carole. Bionanomaterials for the Delivery of Cancer Immunotherapy. In: Chimia, 2019, vol. 73, n° 1, p. 69‑72. doi: 10.2533/chimia.2019.69
- MOTTAS, Inès et al. Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation. In: Biomaterials, 2019, vol. 190-191, p. 111‑120. doi: 10.1016/j.biomaterials.2018.10.031
2018
Articles scientifiques
- SPÖRING, Imke et al. Hook length of the bacterial flagellum is optimized for maximal stability of the flagellar bundle. In: PLOS Biology, 2018, vol. 16, n° 9, p. e2006989. doi: 10.1371/journal.pbio.2006989
- LUCKE, Matthias et al. Engineered hybrid spider silk particles as delivery system for peptide vaccines. In: Biomaterials, 2018, vol. 172, p. 105‑115. doi: 10.1016/j.biomaterials.2018.04.008
- WIDMER, Jérôme et al. Polymer-based nanoparticles loaded with a TLR7 ligand to target the lymph node for immunostimulation. In: International Journal of Pharmaceutics, 2018, vol. 535, n° 1-2, p. 444‑451. doi: 10.1016/j.ijpharm.2017.11.031
2017
Articles scientifiques
- SECONDINI, Chiara et al. Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockade. In: Oncoimmunology, 2017, vol. 6, n° 6, p. e1316437. doi: 10.1080/2162402X.2017.1316437
- OBERSON, Anne et al. NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon response. In: Oncotarget, 2017, vol. 9, n° 5, p. 5641‑5651. doi: 10.18632/oncotarget.23725
- PRIEBE, Magdalena et al. Antimicrobial silver-filled silica nanorattles with low immunotoxicity in dendritic cells. In: Nanomedicine, 2017, vol. 13, n° 1, p. 11‑22. doi: 10.1016/j.nano.2016.08.002
- MOTTAS, Inès et al. A rapid screening method to evaluate the impact of nanoparticles on macrophages. In: Nanoscale, 2017, vol. 9, n° 7, p. 2492‑2504. doi: 10.1039/c6nr08194k
2016
Articles scientifiques
- SPINETTI, Thibaud et al. TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function. In: Oncoimmunology, 2016, vol. 5, n° 11, p. e1230578. doi: 10.1080/2162402X.2016.1230578
- HOTZ, Christian et al. Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses. In: Oncoimmunology, 2016, vol. 5, n° 11, p. e1232219. doi: 10.1080/2162402X.2016.1232219